| Bacteriophage therapeutics: a primer for clinicians on phage‐antibiotic combinations T Morrisette, R Kebriaei, KL Lev, S Morales, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (2 …, 2020 | 81 | 2020 |
| Bacteriophage-antibiotic combination strategy: an alternative against methicillin-resistant phenotypes of Staphylococcus aureus R Kebriaei, K Lev, T Morrisette, KC Stamper, JC Abdul-Mutakabbir, ... Antimicrobial agents and chemotherapy 64 (7), 10.1128/aac. 00461-20, 2020 | 41 | 2020 |
| Bacteriophage-antibiotic combinations for Enterococcus faecium with varying bacteriophage and daptomycin susceptibilities T Morrisette, KL Lev, R Kebriaei, JC Abdul-Mutakabbir, KC Stamper, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00993-20, 2020 | 33 | 2020 |
| Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model S Jahanbakhsh, NB Singh, J Yim, R Kebriaei, JR Smith, K Lev, TT Tran, ... Antimicrobial agents and chemotherapy 64 (5), 10.1128/aac. 02074-19, 2020 | 28 | 2020 |
| Pseudouridine synthase 7 is an opportunistic enzyme that binds and modifies substrates with diverse sequences and structures MK Purchal, DE Eyler, M Tardu, MK Franco, MM Korn, T Khan, ... Proceedings of the National Academy of Sciences 119 (4), e2109708119, 2022 | 27 | 2022 |
| Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination R Kebriaei, KL Lev, RM Shah, KC Stamper, DJ Holger, T Morrisette, ... Microbiology Spectrum 10 (2), e00411-22, 2022 | 23 | 2022 |
| Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections D Holger, R Kebriaei, T Morrisette, K Lev, J Alexander, M Rybak Antibiotics 10 (5), 556, 2021 | 19 | 2021 |
| Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening ASA Mady, C Liao, N Bajwa, KJ Kump, FA Abulwerdi, KL Lev, L Miao, ... Scientific reports 8 (1), 10210, 2018 | 18 | 2018 |
| Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model R Kebriaei, KL Lev, KC Stamper, SM Lehman, S Morales, MJ Rybak Antimicrobial agents and chemotherapy 65 (1), 10.1128/aac. 01863-20, 2020 | 16 | 2020 |
| Bacteriophage‐antibiotic combination therapy for multidrug‐resistant Pseudomonas aeruginosa: In vitro synergy testing DJ Holger, KL Lev, R Kebriaei, T Morrisette, R Shah, J Alexander, ... Journal of Applied Microbiology 133 (3), 1636-1649, 2022 | 15 | 2022 |
| Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic … JC Abdul-Mutakabbir, R Kebriaei, KC Stamper, Z Sheikh, PT Maassen, ... Antibiotics 9 (10), 696, 2020 | 14 | 2020 |
| Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium K Lev, AJ Kunz Coyne, R Kebriaei, T Morrisette, K Stamper, DJ Holger, ... Antibiotics 11 (3), 392, 2022 | 11 | 2022 |
| Evaluation of bacteriophage cocktails alone and in combination with daptomycin against daptomycin-nonsusceptible Enterococcus faecium T Morrisette, KL Lev, GS Canfield, BA Duerkop, R Kebriaei, KC Stamper, ... Antimicrobial Agents and Chemotherapy 66 (1), e01623-21, 2022 | 7 | 2022 |
| Exebacase in addition to daptomycin against MRSA R Kebriaei, KC Stamper, KL Lev, T Morrisette, JC Abdul-Mutakabbir, ... Antimicrobial Agents and Chemotherapy 65 (11), 10.1128/aac. 00128-21, 2021 | 6 | 2021 |
| 1295. Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant Pseudomonas aeruginosa Strains JC Abdul-Mutakabbir, L Nguyen, K Stamper, P Maassen, K Lev, ... Open Forum Infectious Diseases 7 (Supplement_1), S662-S663, 2020 | 3 | 2020 |
| 1297. In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant Acinetobacter baumannii JC Abdul-Mutakabbir, L Nguyen, P Maassen, K Stamper, R Kebriaei, ... Open Forum Infectious Diseases 7 (Suppl 1), S663, 2020 | 3 | 2020 |
| Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models DJ Holger, A El Ghali, N Bhutani, KL Lev, K Stamper, R Kebriaei, ... Antimicrobial Agents and Chemotherapy 67 (11), e00578-23, 2023 | 2 | 2023 |
| Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic … T Morrisette, KC Stamper, KL Lev, R Kebriaei, DJ Holger, ... Antimicrobial Agents and Chemotherapy 67 (6), e01317-22, 2023 | 1 | 2023 |
| Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin R Kebriaei, JC Abdul-Mutakabbir, KC Stamper, KL Lev, MJ Rybak Infectious diseases and therapy 12 (10), 2485-2494, 2023 | | 2023 |
| 132. Evaluation Phage Cocktails in Combination with Ciprofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Overexpressing MexAB-OprM Efflux Systems D Holger, K Lev, N Bhutani, R Kebriaei, T Morrisette, S Lehman, ... Open Forum Infectious Diseases 8 (Suppl 1), S81, 2021 | | 2021 |
